{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T17:28:33Z","timestamp":1793035713005,"version":"4.5.0"},"reference-count":89,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2025,4,22]],"date-time":"2025-04-22T00:00:00Z","timestamp":1745280000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,4,22]],"date-time":"2025-04-22T00:00:00Z","timestamp":1745280000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100019180","name":"EC | ERC | HORIZON EUROPE European Research Council","doi-asserted-by":"publisher","award":["101142691-QtCilia"],"award-info":[{"award-number":["101142691-QtCilia"]}],"id":[{"id":"10.13039\/100019180","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100019180","name":"EC | ERC | HORIZON EUROPE European Research Council","doi-asserted-by":"publisher","award":["TheRaCiL-101080717"],"award-info":[{"award-number":["TheRaCiL-101080717"]}],"id":[{"id":"10.13039\/100019180","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100020581","name":"Fondazione AIRC per la ricerca sul cancro ETS","doi-asserted-by":"publisher","award":["IG2024-30769"],"award-info":[{"award-number":["IG2024-30769"]}],"id":[{"id":"10.13039\/100020581","id-type":"DOI","asserted-by":"publisher"}]},{"name":"EC"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["EMBO Mol Med"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Primary cilia are solitary organelles formed by a microtubule-based skeleton protruding in a single copy on the surface of most cells. Alterations in their function cause a plethora of human conditions collectively called the ciliopathies. The kidney is frequently and severely affected in the ciliopathies, presenting with a spectrum of phenotypes. Cyst formation is a common trait of all renal ciliopathies. Besides this common manifestation, however, the renal ciliopathies present with profoundly different phenotypes, resulting in either polycystic kidney disease (PKD) or nephronophthisis (NPH) phenotypes. The past decade has seen a surge of studies highlighting metabolic reprogramming as a major feature of PKD, with a distinct involvement of mitochondrial dysfunction. This discovery has brought forward the development of novel therapeutic approaches. More recent evidence suggests that primary cilia modulate the mitochondrial production of energy in response to environmental cues. Here, we summarize the evidence available to date and propose a more general involvement of metabolic and mitochondrial alterations in the renal ciliopathies that might in principle help defining the profoundly different, and potentially opposite, manifestations observed.<\/jats:p>","DOI":"10.1038\/s44321-025-00239-x","type":"journal-article","created":{"date-parts":[[2025,4,22]],"date-time":"2025-04-22T08:33:19Z","timestamp":1745310799000},"page":"1191-1202","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Metabolic reprogramming in polycystic kidney disease and other renal ciliopathies"],"prefix":"10.1038","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3911-9944","authenticated-orcid":false,"given":"Sara","family":"Clerici","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4704-4006","authenticated-orcid":false,"given":"Alessandra","family":"Boletta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,22]]},"reference":[{"key":"239_CR1","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1038\/s41581-019-0116-9","volume":"15","author":"Z Anvarian","year":"2019","unstructured":"Anvarian Z, Mykytyn K, Mukhopadhyay S, Pedersen LB, Christensen ST (2019) Cellular signalling by primary cilia in development, organ function and disease. Nat Rev Nephrol 15:199\u2013219","journal-title":"Nat Rev Nephrol"},{"key":"239_CR2","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1007\/s00467-012-2259-9","volume":"28","author":"HH Arts","year":"2013","unstructured":"Arts HH, Knoers NVAM (2013) Current insights into renal ciliopathies: what can genetics teach us? Pediatr Nephrol 28:863\u2013874","journal-title":"Pediatr Nephrol"},{"key":"239_CR3","doi-asserted-by":"publisher","first-page":"111351","DOI":"10.1016\/j.cellsig.2024.111351","volume":"123","author":"D Atwood","year":"2024","unstructured":"Atwood D, He Z, Miyazaki M, Hailu F, Klawitter J, Edelstein CL (2024) Early treatment with 2-deoxy-d-glucose reduces proliferative proteins in the kidney and slows cyst growth in a hypomorphic Pkd1 mouse model of autosomal dominant polycystic kidney disease (PKD). Cell Signal 123:111351","journal-title":"Cell Signal"},{"key":"239_CR4","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-019-2184-y","volume":"10","author":"J-E Bae","year":"2019","unstructured":"Bae J-E, Kang GM, Min SH, Jo DS, Jung Y-K, Kim K, Kim M-S, Cho D-H (2019) Primary cilia mediate mitochondrial stress responses to promote dopamine neuron survival in a Parkinson\u2019s disease model. Cell Death Dis 10:952","journal-title":"Cell Death Dis"},{"key":"239_CR5","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-84609-8","volume":"11","author":"MM Baliga","year":"2021","unstructured":"Baliga MM, Klawitter J, Christians U, Hopp K, Chonchol M, Gitomer BY, Cadnapaphornchai MA, Klawitter J (2021) Metabolic profiling in children and young adults with autosomal dominant polycystic kidney disease. Sci Rep 11:6629","journal-title":"Sci Rep"},{"key":"239_CR6","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a028175","volume":"9","author":"F Bangs","year":"2017","unstructured":"Bangs F, Anderson KV (2017) Primary cilia and mammalian hedgehog signaling. Cold Spring Harb Perspect Biol 9:a028175","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"239_CR7","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1038\/s41572-018-0047-y","volume":"4","author":"C Bergmann","year":"2018","unstructured":"Bergmann C, Guay-Woodford LM, Harris PC, Horie S, Peters DJM, Torres VE (2018) Polycystic kidney disease. Nat Rev Dis Prim 4:50","journal-title":"Nat Rev Dis Prim"},{"key":"239_CR8","doi-asserted-by":"publisher","first-page":"274376","DOI":"10.1155\/2010\/274376","volume":"2010","author":"BL Blazer-Yost","year":"2010","unstructured":"Blazer-Yost BL, Haydon J, Eggleston-Gulyas T, Chen J-H, Wang X, Gattone V, Torres VE (2010) Pioglitazone attenuates cystic burden in the PCK rodent model of polycystic kidney disease. PPAR Res 2010:274376","journal-title":"PPAR Res"},{"key":"239_CR9","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1038\/ncb2117","volume":"12","author":"C Boehlke","year":"2010","unstructured":"Boehlke C, Kotsis F, Patel V, Braeg S, Voelker H, Bredt S, Beyer T, Janusch H, Hamann C, G\u00f6del M et al (2010) Primary cilia regulate mTORC1 activity and cell size through Lkb1. Nat Cell Biol 12:1115\u20131122","journal-title":"Nat Cell Biol"},{"key":"239_CR10","doi-asserted-by":"crossref","unstructured":"Boletta A, Caplan MJ (2025) Physiologic mechanisms underlying polycystic kidney disease. Physiol Rev 105:1553\u20131607","DOI":"10.1152\/physrev.00018.2024"},{"key":"239_CR11","doi-asserted-by":"crossref","unstructured":"Burgmaier K, Kilian S, Arbeiter K, Atmis B, Boyer O, Buescher A, Dursun I, Erger F, Fila M, Galiano M et al (2025) A risk score to predict kidney survival in patients with autosomal recessive polycystic kidney disease at the age of two months. Kidney Int 107:903\u2013915","DOI":"10.1016\/j.kint.2025.01.023"},{"key":"239_CR12","doi-asserted-by":"publisher","first-page":"6493","DOI":"10.1096\/fj.201901739RR","volume":"34","author":"L Cassina","year":"2020","unstructured":"Cassina L, Chiaravalli M, Boletta A (2020) Increased mitochondrial fragmentation in polycystic kidney disease acts as a modifier of disease progression. FASEB J 34:6493\u20136507","journal-title":"FASEB J"},{"key":"239_CR13","doi-asserted-by":"publisher","first-page":"dev201976","DOI":"10.1242\/dev.201976","volume":"150","author":"T Cheng","year":"2023","unstructured":"Cheng T, Agwu C, Shim K, Wang B, Jain S, Mahjoub MR (2023) Aberrant centrosome biogenesis disrupts nephron and collecting duct progenitor growth and fate resulting in fibrocystic kidney disease. Development 150:dev201976","journal-title":"Development"},{"key":"239_CR14","doi-asserted-by":"publisher","first-page":"1958","DOI":"10.1681\/ASN.2015030231","volume":"27","author":"M Chiaravalli","year":"2016","unstructured":"Chiaravalli M, Rowe I, Mannella V, Quilici G, Canu T, Bianchi V, Gurgone A, Antunes S, D\u2019Adamo P, Esposito A et al (2016) 2-Deoxy-d-glucose ameliorates PKD progression. J Am Soc Nephrol 27:1958\u20131969","journal-title":"J Am Soc Nephrol"},{"key":"239_CR15","doi-asserted-by":"publisher","first-page":"F414","DOI":"10.1152\/ajprenal.00167.2018","volume":"316","author":"P Chumley","year":"2019","unstructured":"Chumley P, Zhou J, Mrug S, Chacko B, Parant JM, Challa AK, Wilson LS, Berryhill TF, Barnes S, Kesterson RA et al (2019) Truncating PKHD1 and PKD2 mutations alter energy metabolism. Am J Physiol-Ren Physiol 316:F414\u2013F425","journal-title":"Am J Physiol-Ren Physiol"},{"key":"239_CR16","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1016\/j.cmet.2019.08.003","volume":"30","author":"KW Chung","year":"2019","unstructured":"Chung KW, Dhillon P, Huang S, Sheng X, Shrestha R, Qiu C, Kaufman BA, Park J, Pei L, Baur J et al (2019) Mitochondrial damage and activation of the STING pathway lead to renal inflammation and fibrosis. Cell Metab 30:784\u2013799.e5","journal-title":"Cell Metab"},{"key":"239_CR17","doi-asserted-by":"publisher","first-page":"1379","DOI":"10.1038\/s44321-024-00071-9","volume":"16","author":"S Clerici","year":"2024","unstructured":"Clerici S, Podrini C, Stefanoni D, Distefano G, Cassina L, Steidl ME, Tronci L, Canu T, Chiaravalli M, Spies D et al (2024) Inhibition of asparagine synthetase effectively retards polycystic kidney disease progression. EMBO Mol Med 16:1379\u20131403","journal-title":"EMBO Mol Med"},{"key":"239_CR18","doi-asserted-by":"publisher","first-page":"1200","DOI":"10.1038\/s42003-021-02730-w","volume":"4","author":"N Daneshgar","year":"2021","unstructured":"Daneshgar N, Baguley AW, Liang P-I, Wu F, Chu Y, Kinter MT, Benavides GA, Johnson MS, Darley-Usmar V, Zhang J et al (2021) Metabolic derangement in polycystic kidney disease mouse models is ameliorated by mitochondrial-targeted antioxidants. Commun Biol 4:1200","journal-title":"Commun Biol"},{"key":"239_CR19","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.gde.2019.07.005","volume":"56","author":"LA Devlin","year":"2019","unstructured":"Devlin LA, Sayer JA (2019) Renal ciliopathies. Curr Opin Genet Dev 56:49\u201360","journal-title":"Curr Opin Genet Dev"},{"key":"239_CR20","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2317344121","volume":"121","author":"BI Fedeles","year":"2024","unstructured":"Fedeles BI, Bhardwaj R, Ishikawa Y, Khumsubdee S, Krappitz M, Gubina N, Volpe I, Andrade DC, Westergerling P, Staudner T et al (2024) A synthetic agent ameliorates polycystic kidney disease by promoting apoptosis of cystic cells through increased oxidative stress. Proc Natl Acad Sci USA 121:e2317344121","journal-title":"Proc Natl Acad Sci USA"},{"key":"239_CR21","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-03036-y","volume":"9","author":"EM Flowers","year":"2018","unstructured":"Flowers EM, Sudderth J, Zacharias L, Mernaugh G, Zent R, DeBerardinis RJ, Carroll TJ (2018) Lkb1 deficiency confers glutamine dependency in polycystic kidney disease. Nat Commun 9:814","journal-title":"Nat Commun"},{"key":"239_CR22","doi-asserted-by":"publisher","DOI":"10.15252\/embj.2023113891","volume":"42","author":"J Gopalakrishnan","year":"2023","unstructured":"Gopalakrishnan J, Feistel K, Friedrich BM, Grapin\u2010Botton A, Jurisch\u2010Yaksi N, Mass E, Mick DU, M\u00fcller R, May\u2010Simera H, Schermer B et al (2023) Emerging principles of primary cilia dynamics in controlling tissue organization and function. EMBO J 42:e113891","journal-title":"EMBO J"},{"key":"239_CR23","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pgen.1005890","volume":"12","author":"D-F Guo","year":"2016","unstructured":"Guo D-F, Cui H, Zhang Q, Morgan DA, Thedens DR, Nishimura D, Grobe JL, Sheffield VC, Rahmouni K (2016) The BBSome controls energy homeostasis by mediating the transport of the leptin receptor to the plasma membrane. PLoS Genet 12:e1005890","journal-title":"PLoS Genet"},{"key":"239_CR24","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms14395","volume":"8","author":"S Hajarnis","year":"2017","unstructured":"Hajarnis S, Lakhia R, Yheskel M, Williams D, Sorourian M, Liu X, Aboudehen K, Zhang S, Kersjes K, Galasso R et al (2017) microRNA-17 family promotes polycystic kidney disease progression through modulation of mitochondrial metabolism. Nat Commun 8:14395","journal-title":"Nat Commun"},{"key":"239_CR25","doi-asserted-by":"publisher","first-page":"1449","DOI":"10.1016\/j.ekir.2023.04.006","volume":"8","author":"AA Halawi","year":"2023","unstructured":"Halawi AA, Burgmaier K, Buescher AK, Dursun I, Erger F, Galiano M, Gessner M, G\u00f6kce I, Mekahli D, Mir S et al (2023) Clinical characteristics and courses of patients with autosomal recessive polycystic kidney disease-mimicking phenocopies. Kidney Int Rep 8:1449\u20131454","journal-title":"Kidney Int Rep"},{"key":"239_CR26","doi-asserted-by":"publisher","DOI":"10.15252\/embr.202154315","volume":"23","author":"JN Hansen","year":"2022","unstructured":"Hansen JN, Kaiser F, Leyendecker P, St\u00fcven B, Krause J, Derakhshandeh F, Irfan J, Sroka TJ, Preval KM, Desai PB et al (2022) A cAMP signalosome in primary cilia drives gene expression and kidney cyst formation. EMBO Rep 23:e54315","journal-title":"EMBO Rep"},{"key":"239_CR27","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.1016\/j.cell.2019.11.005","volume":"179","author":"KI Hilgendorf","year":"2019","unstructured":"Hilgendorf KI, Johnson CT, Mezger A, Rice SL, Norris AM, Demeter J, Greenleaf WJ, Reiter JF, Kopinke D, Jackson PK (2019) Omega-3 fatty acids activate ciliary FFAR4 to control adipogenesis. Cell 179:1289\u20131305.e21","journal-title":"Cell"},{"key":"239_CR89","doi-asserted-by":"crossref","unstructured":"Hoff S et al (2013) ANKS6 is a central component of a nephronophthisis module linking NEK8 to INVS and NPHP3. Nat Genet 45:951\u2013956","DOI":"10.1038\/ng.2681"},{"key":"239_CR28","doi-asserted-by":"publisher","first-page":"8912","DOI":"10.1073\/pnas.2001936117","volume":"117","author":"JW Hughes","year":"2020","unstructured":"Hughes JW, Cho JH, Conway HE, DiGruccio MR, Ng XW, Roseman HF, Abreu D, Urano F, Piston DW (2020) Primary cilia control glucose homeostasis via islet paracrine interactions. Proc Natl Acad Sci USA 117:8912\u20138923","journal-title":"Proc Natl Acad Sci USA"},{"key":"239_CR29","doi-asserted-by":"publisher","first-page":"F492","DOI":"10.1152\/ajprenal.00238.2015","volume":"309","author":"VJ Hwang","year":"2015","unstructured":"Hwang VJ, Kim J, Rand A, Yang C, Sturdivant S, Hammock B, Bell PD, Guay-Woodford LM, Weiss RH (2015) The cpk model of recessive PKD shows glutamine dependence associated with the production of the oncometabolite 2-hydroxyglutarate. Am J Physiol-Ren Physiol 309:F492\u2013F498","journal-title":"Am J Physiol-Ren Physiol"},{"key":"239_CR30","doi-asserted-by":"publisher","DOI":"10.1128\/MCB.00337-17","volume":"37","author":"Y Ishimoto","year":"2017","unstructured":"Ishimoto Y, Inagi R, Yoshihara D, Kugita M, Nagao S, Shimizu A, Takeda N, Wake M, Honda K, Zhou J et al (2017) Mitochondrial abnormality facilitates cyst formation in autosomal dominant polycystic kidney disease. Mol Cell Biol 37:e00337-17","journal-title":"Mol Cell Biol"},{"key":"239_CR31","doi-asserted-by":"publisher","first-page":"1994","DOI":"10.3390\/ijms21061994","volume":"21","author":"AS Kahveci","year":"2020","unstructured":"Kahveci AS, Barnatan TT, Kahveci A, Adrian AE, Arroyo J, Eirin A, Harris PC, Lerman A, Lerman LO, Torres VE et al (2020) Oxidative stress and mitochondrial abnormalities contribute to decreased endothelial nitric oxide synthase expression and renal disease progression in early experimental polycystic kidney disease. Int J Mol Sci 21:1994","journal-title":"Int J Mol Sci"},{"key":"239_CR32","doi-asserted-by":"publisher","first-page":"73","DOI":"10.5483\/BMBRep.2013.46.2.022","volume":"46","author":"JY Ko","year":"2013","unstructured":"Ko JY, Park JH (2013) Mouse models of polycystic kidney disease induced by defects of ciliary proteins. BMB Rep 46:73\u201379","journal-title":"BMB Rep"},{"key":"239_CR33","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1007\/s00109-015-1337-4","volume":"94","author":"A Kraus","year":"2016","unstructured":"Kraus A, Schley G, Kunzelmann K, Schreiber R, Peters DJM, Stadler R, Eckardt K-U, Buchholz B (2016) Glucose promotes secretion-dependent renal cyst growth. J Mol Med 94:107\u2013117","journal-title":"J Mol Med"},{"key":"239_CR34","doi-asserted-by":"publisher","first-page":"F122","DOI":"10.1152\/ajprenal.00352.2017","volume":"314","author":"R Lakhia","year":"2018","unstructured":"Lakhia R, Yheskel M, Flaten A, Quittner-Strom EB, Holland WL, Patel V (2018) PPAR\u03b1 agonist fenofibrate enhances fatty acid \u03b2-oxidation and attenuates polycystic kidney and liver disease in mice. Am J Physiol-Ren Physiol 314:F122\u2013F131","journal-title":"Am J Physiol-Ren Physiol"},{"key":"239_CR35","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-11918-y","volume":"10","author":"EC Lee","year":"2019","unstructured":"Lee EC, Valencia T, Allerson C, Schairer A, Flaten A, Yheskel M, Kersjes K, Li J, Gatto S, Takhar M et al (2019) Discovery and preclinical evaluation of anti-miR-17 oligonucleotide RGLS4326 for the treatment of polycystic kidney disease. Nat Commun 10:4148","journal-title":"Nat Commun"},{"key":"239_CR36","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1016\/j.cub.2019.01.054","volume":"29","author":"E Legu\u00e9","year":"2019","unstructured":"Legu\u00e9 E, Liem KF (2019) Tulp3 is a ciliary trafficking gene that regulates polycystic kidney disease. Curr Biol 29:803\u2013812.e5","journal-title":"Curr Biol"},{"key":"239_CR37","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-35537-2","volume":"13","author":"SR Li","year":"2022","unstructured":"Li SR, Gulieva RE, Helms L, Cruz NM, Vincent T, Fu H, Himmelfarb J, Freedman BS (2022) Glucose absorption drives cystogenesis in a human organoid-on-chip model of polycystic kidney disease. Nat Commun 13:7918","journal-title":"Nat Commun"},{"key":"239_CR38","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1111\/bph.14558","volume":"176","author":"X Lian","year":"2019","unstructured":"Lian X, Wu X, Li Z, Zhang Y, Song K, Cai G, Li Q, Lin S, Chen X, Bai X (2019) The combination of metformin and 2\u2010deoxyglucose significantly inhibits cyst formation in miniature pigs with polycystic kidney disease. Br J Pharm 176:711\u2013724","journal-title":"Br J Pharm"},{"key":"239_CR39","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1016\/j.bbrc.2017.05.060","volume":"488","author":"X Lian","year":"2017","unstructured":"Lian X, Zhao J, Wu X, Zhang Y, Li Q, Lin S, Bai X-Y, Chen X (2017) The changes in glucose metabolism and cell proliferation in the kidneys of polycystic kidney disease mini-pig models. Biochem Biophys Res Commun 488:374\u2013381","journal-title":"Biochem Biophys Res Commun"},{"key":"239_CR40","doi-asserted-by":"publisher","first-page":"2743","DOI":"10.1038\/s41598-018-20856-6","volume":"8","author":"C-C Lin","year":"2018","unstructured":"Lin C-C, Kurashige M, Liu Y, Terabayashi T, Ishimoto Y, Wang T, Choudhary V, Hobbs R, Liu L-K, Lee P-H et al (2018) A cleavage product of Polycystin-1 is a mitochondrial matrix protein that affects mitochondria morphology and function when heterologously expressed. Sci Rep 8:2743","journal-title":"Sci Rep"},{"key":"239_CR41","doi-asserted-by":"publisher","first-page":"1307","DOI":"10.1016\/j.kint.2016.03.006","volume":"89","author":"D Lu","year":"2016","unstructured":"Lu D, Rauhauser A, Li B, Ren C, McEnery K, Zhu J, Chaki M, Vadnagara K, Elhadi S, Jetten AM et al (2016) Loss of Glis2\/NPHP7 causes kidney epithelial cell senescence and suppresses cyst growth in the Kif3a mouse model of cystic kidney disease. Kidney Int 89:1307\u20131323","journal-title":"Kidney Int"},{"key":"239_CR42","doi-asserted-by":"publisher","first-page":"eaba3613","DOI":"10.1126\/scitranslmed.aba3613","volume":"12","author":"Y Lu","year":"2020","unstructured":"Lu Y, Sun Y, Liu Z, Lu Y, Zhu X, Lan B, Mi Z, Dang L, Li N, Zhan W et al (2020) Activation of NRF2 ameliorates oxidative stress and cystogenesis in autosomal dominant polycystic kidney disease. Sci Transl Med 12:eaba3613","journal-title":"Sci Transl Med"},{"key":"239_CR43","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.semcdb.2020.05.003","volume":"110","author":"M Ma","year":"2021","unstructured":"Ma M (2021) Cilia and polycystic kidney disease. Semin Cell Dev Biol 110:139\u2013148","journal-title":"Semin Cell Dev Biol"},{"key":"239_CR44","doi-asserted-by":"publisher","first-page":"1004","DOI":"10.1038\/ng.2715","volume":"45","author":"M Ma","year":"2013","unstructured":"Ma M, Tian X, Igarashi P, Pazour GJ, Somlo S (2013) Loss of cilia suppresses cyst growth in genetic models of autosomal dominant polycystic kidney disease. Nat Genet 45:1004\u20131012","journal-title":"Nat Genet"},{"key":"239_CR45","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.ebiom.2016.01.027","volume":"5","author":"LF Menezes","year":"2016","unstructured":"Menezes LF, Lin C-C, Zhou F, Germino GG (2016) Fatty acid oxidation is impaired in an orthologous mouse model of autosomal dominant polycystic kidney disease. Ebiomedicine 5:183\u2013192","journal-title":"Ebiomedicine"},{"key":"239_CR46","doi-asserted-by":"publisher","first-page":"e1003053","DOI":"10.1371\/journal.pgen.1003053","volume":"8","author":"LF Menezes","year":"2012","unstructured":"Menezes LF, Zhou F, Patterson AD, Piontek KB, Krausz KW, Gonzalez FJ, Germino GG (2012) Network analysis of a Pkd1-mouse model of autosomal dominant polycystic kidney disease identifies HNF4\u03b1 as a disease modifier. PLoS Genet 8:e1003053","journal-title":"PLoS Genet"},{"key":"239_CR47","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1038\/s41556-020-0566-0","volume":"22","author":"C Miceli","year":"2020","unstructured":"Miceli C, Roccio F, Penalva-Mousset L, Burtin M, Leroy C, Nemazanyy I, Kuperwasser N, Pontoglio M, Friedlander G, Morel E et al (2020) The primary cilium and lipophagy translate mechanical forces to direct metabolic adaptation of kidney epithelial cells. Nat Cell Biol 22:1091\u20131102","journal-title":"Nat Cell Biol"},{"key":"239_CR48","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1038\/s41581-024-00889-z","volume":"21","author":"V Miguel","year":"2025","unstructured":"Miguel V, Shaw IW, Kramann R (2025) Metabolism at the crossroads of inflammation and fibrosis in chronic kidney disease. Nat Rev Nephrol 21:39\u201356","journal-title":"Nat Rev Nephrol"},{"key":"239_CR49","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-34255-z","volume":"13","author":"Y Muto","year":"2022","unstructured":"Muto Y, Dixon EE, Yoshimura Y, Wu H, Omachi K, Ledru N, Wilson PC, King AJ, Olson NE, Gunawan MG et al (2022) Defining cellular complexity in human autosomal dominant polycystic kidney disease by multimodal single cell analysis. Nat Commun 13:6497","journal-title":"Nat Commun"},{"key":"239_CR50","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1038\/88925","volume":"28","author":"K Mykytyn","year":"2001","unstructured":"Mykytyn K, Braun T, Carmi R, Haider NB, Searby CC, Shastri M, Beck G, Wright AF, Iannaccone A, Elbedour K et al (2001) Identification of the gene that, when mutated, causes the human obesity syndrome BBS4. Nat Genet 28:188\u2013191","journal-title":"Nat Genet"},{"key":"239_CR51","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.154773","volume":"8","author":"DT Nguyen","year":"2022","unstructured":"Nguyen DT, Kleczko EK, Dwivedi N, Monaghan M-LT, Gitomer BY, Chonchol MB, Clambey ET, Nemenoff RA, Klawitter J, Hopp K (2022) The tryptophan metabolizing enzyme indoleamine 2,3-dioxygenase 1 regulates polycystic kidney disease progression. JCI Insight 8:e154773","journal-title":"JCI Insight"},{"key":"239_CR52","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.cmet.2014.11.019","volume":"21","author":"EC Oh","year":"2015","unstructured":"Oh EC, Vasanth S, Katsanis N (2015) Metabolic regulation and energy homeostasis through the primary cilium. Cell Metab 21:21\u201331","journal-title":"Cell Metab"},{"key":"239_CR53","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1038\/ki.2015.207","volume":"88","author":"ACM Ong","year":"2015","unstructured":"Ong ACM, Harris PC (2015) A polycystin-centric view of cyst formation and disease: the polycystins revisited. Kidney Int 88:699\u2013710","journal-title":"Kidney Int"},{"key":"239_CR54","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-37449-1","volume":"14","author":"L Onuchic","year":"2023","unstructured":"Onuchic L, Padovano V, Schena G, Rajendran V, Dong K, Shi X, Pandya R, Rai V, Gresko NP, Ahmed O et al (2023) The C-terminal tail of polycystin-1 suppresses cystic disease in a mitochondrial enzyme-dependent fashion. Nat Commun 14:1790","journal-title":"Nat Commun"},{"key":"239_CR55","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1091\/mbc.e16-08-0597","volume":"28","author":"V Padovano","year":"2017","unstructured":"Padovano V, Kuo IY, Stavola LK, Aerni HR, Flaherty BJ, Chapin HC, Ma M, Somlo S, Boletta A, Ehrlich BE et al (2017) The polycystins are modulated by cellular oxygen-sensing pathways and regulate mitochondrial function. Mol Biol Cell 28:261\u2013269","journal-title":"Mol Biol Cell"},{"key":"239_CR56","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1038\/s41581-018-0051-1","volume":"14","author":"V Padovano","year":"2018","unstructured":"Padovano V, Podrini C, Boletta A, Caplan MJ (2018) Metabolism and mitochondria in polycystic kidney disease research and therapy. Nat Rev Nephrol 14:678\u2013687","journal-title":"Nat Rev Nephrol"},{"key":"239_CR57","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1038\/nature12639","volume":"502","author":"O Pampliega","year":"2013","unstructured":"Pampliega O, Orhon I, Patel B, Sridhar S, D\u00edaz-Carretero A, Beau I, Codogno P, Satir BH, Satir P, Cuervo AM (2013) Functional interaction between autophagy and ciliogenesis. Nature 502:194\u2013200","journal-title":"Nature"},{"key":"239_CR58","doi-asserted-by":"publisher","first-page":"10765","DOI":"10.1073\/pnas.1301693110","volume":"110","author":"V Patel","year":"2013","unstructured":"Patel V, Williams D, Hajarnis S, Hunter R, Pontoglio M, Somlo S, Igarashi P (2013) miR-17\u223c92 miRNA cluster promotes kidney cyst growth in polycystic kidney disease. Proc Natl Acad Sci USA 110:10765\u201310770","journal-title":"Proc Natl Acad Sci USA"},{"key":"239_CR59","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms10786","volume":"7","author":"M Pema","year":"2016","unstructured":"Pema M, Drusian L, Chiaravalli M, Castelli M, Yao Q, Ricciardi S, Somlo S, Qian F, Biffo S, Boletta A (2016) mTORC1-mediated inhibition of polycystin-1 expression drives renal cyst formation in tuberous sclerosis complex. Nat Commun 7:10786","journal-title":"Nat Commun"},{"key":"239_CR60","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1016\/j.kint.2023.05.007","volume":"104","author":"F Petzold","year":"2023","unstructured":"Petzold F, Billot K, Chen X, Henry C, Filhol E, Martin Y, Avramescu M, Douillet M, Morini\u00e8re V, Krug P et al (2023) The genetic landscape and clinical spectrum of nephronophthisis and related ciliopathies. Kidney Int 104:378\u2013387","journal-title":"Kidney Int"},{"key":"239_CR61","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1038\/s42003-018-0200-x","volume":"1","author":"C Podrini","year":"2018","unstructured":"Podrini C, Rowe I, Pagliarini R, Costa ASH, Chiaravalli M, Meo ID, Kim H, Distefano G, Tiranti V, Qian F et al (2018) Dissection of metabolic reprogramming in polycystic kidney disease reveals coordinated rewiring of bioenergetic pathways. Commun Biol 1:194","journal-title":"Commun Biol"},{"key":"239_CR62","doi-asserted-by":"publisher","DOI":"10.1186\/s12964-024-01481-5","volume":"22","author":"M Pu","year":"2024","unstructured":"Pu M, Zhang J, Hong F, Wang Y, Zhang C, Zeng Y, Fang Z, Qi W, Yang X, Gao G et al (2024) The pathogenic role of succinate-SUCNR1: a critical function that induces renal fibrosis via M2 macrophage. Cell Commun Signal 22:78","journal-title":"Cell Commun Signal"},{"key":"239_CR63","doi-asserted-by":"publisher","unstructured":"Qu Q, Chen Y, Wang Y, Wang W, Long S, Yang H-Y, Wu J, Li M, Tian X, Wei X et al (2024) Lithocholic acid binds TULP3 to activate sirtuins and AMPK to slow down ageing. Nature 1\u20139. https:\/\/doi.org\/10.1038\/s41586-024-08348-2","DOI":"10.1038\/s41586-024-08348-2"},{"issue":"6","key":"239_CR64","doi-asserted-by":"publisher","first-page":"1234","DOI":"10.1016\/j.cmet.2021.03.024","volume":"33","author":"H Ramalingam","year":"2021","unstructured":"Ramalingam H, Kashyap S, Cobo-Stark P, Flaten A, Chang C-M, Hajarnis S, Hein KZ, Lika J, Warner GM, Espindola-Netto JM et al (2021) A methionine-Mettl3-N 6 -methyladenosine axis promotes polycystic kidney disease. Cell Metab 33(6):1234\u20131247.e7","journal-title":"Cell Metab"},{"key":"239_CR65","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1038\/nrm.2017.60","volume":"18","author":"JF Reiter","year":"2017","unstructured":"Reiter JF, Leroux MR (2017) Genes and molecular pathways underpinning ciliopathies. Nat Rev Mol Cell Biol 18:533\u2013547","journal-title":"Nat Rev Mol Cell Biol"},{"key":"239_CR66","doi-asserted-by":"publisher","first-page":"e0146654","DOI":"10.1371\/journal.pone.0146654","volume":"11","author":"M Riwanto","year":"2016","unstructured":"Riwanto M, Kapoor S, Rodriguez D, Edenhofer I, Segerer S, W\u00fcthrich RP (2016) Inhibition of aerobic glycolysis attenuates disease progression in polycystic kidney disease. PLoS ONE 11:e0146654","journal-title":"PLoS ONE"},{"key":"239_CR67","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1038\/nm.3092","volume":"19","author":"I Rowe","year":"2013","unstructured":"Rowe I, Chiaravalli M, Mannella V, Ulisse V, Quilici G, Pema M, Song XW, Xu H, Mari S, Qian F et al (2013) Defective glucose metabolism in polycystic kidney disease identifies a new therapeutic strategy. Nat Med 19:488\u2013493","journal-title":"Nat Med"},{"key":"239_CR68","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-27389-y","volume":"8","author":"M Schlimpert","year":"2018","unstructured":"Schlimpert M, Lagies S, Budnyk V, M\u00fcller B, Walz G, Kammerer B (2018) Metabolic phenotyping of Anks3 depletion in mIMCD-3 cells\u2014a putative nephronophthisis candidate. Sci Rep. 8:9022","journal-title":"Sci Rep."},{"key":"239_CR69","doi-asserted-by":"publisher","DOI":"10.1007\/s11306-019-1535-0","volume":"15","author":"M Schlimpert","year":"2019","unstructured":"Schlimpert M, Lagies S, M\u00fcller B, Budnyk V, Blanz KD, Walz G, Kammerer B (2019) Metabolic perturbations caused by depletion of nephronophthisis factor Anks6 in mIMCD3 cells. Metabolomics 15:71","journal-title":"Metabolomics"},{"key":"239_CR70","doi-asserted-by":"publisher","first-page":"1225","DOI":"10.1016\/j.kint.2020.05.049","volume":"98","author":"L Shao","year":"2020","unstructured":"Shao L, El-Jouni W, Kong F, Ramesh J, Kumar RS, Shen X, Ren J, Devendra S, Dorschel A, Wu M et al (2020) Genetic reduction of cilium length by targeting intraflagellar transport 88 protein impedes kidney and liver cyst formation in mouse models of autosomal polycystic kidney disease. Kidney Int 98:1225\u20131241","journal-title":"Kidney Int"},{"key":"239_CR71","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1681\/ASN.2012020154","volume":"24","author":"N Sharma","year":"2013","unstructured":"Sharma N, Malarkey EB, Berbari NF, O\u2019Connor AK, Heuvel GBV, Mrug M, Yoder BK (2013) Proximal tubule proliferation is insufficient to induce rapid cyst formation after cilia disruption. J Am Soc Nephrol 24:456\u2013464","journal-title":"J Am Soc Nephrol"},{"key":"239_CR72","doi-asserted-by":"publisher","first-page":"2328","DOI":"10.1093\/hmg\/ddp165","volume":"18","author":"X Song","year":"2009","unstructured":"Song X, Giovanni VD, He N, Wang K, Ingram A, Rosenblum ND, Pei Y (2009) Systems biology of autosomal dominant polycystic kidney disease (ADPKD): computational identification of gene expression pathways and integrated regulatory networks. Hum Mol Genet 18:2328\u20132343","journal-title":"Hum Mol Genet"},{"key":"239_CR73","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.1093\/ndt\/gfx349","volume":"33","author":"I Soomro","year":"2018","unstructured":"Soomro I, Sun Y, Li Z, Diggs L, Hatzivassiliou G, Thomas AG, Rais R, Parker SJ, Slusher BS, Kimmelman AC et al (2018) Glutamine metabolism via glutaminase 1 in autosomal-dominant polycystic kidney disease. Nephrol Dial Transpl 33:1343\u20131353","journal-title":"Nephrol Dial Transpl"},{"key":"239_CR74","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1038\/s42255-023-00754-6","volume":"5","author":"ME Steidl","year":"2023","unstructured":"Steidl ME, Nigro EA, Nielsen AK, Pagliarini R, Cassina L, Lampis M, Podrini C, Chiaravalli M, Mannella V, Distefano G et al (2023) Primary cilia sense glutamine availability and respond via asparagine synthetase. Nat Metab 5:385\u2013397","journal-title":"Nat Metab"},{"key":"239_CR75","doi-asserted-by":"publisher","first-page":"F909","DOI":"10.1152\/ajprenal.00722.2009","volume":"298","author":"SL Taylor","year":"2010","unstructured":"Taylor SL, Ganti S, Bukanov NO, Chapman A, Fiehn O, Osier M, Kim K, Weiss RH (2010) A metabolomics approach using juvenile cystic mice to identify urinary biomarkers and altered pathways in polycystic kidney disease. Am J Physiol-Ren Physiol 298:F909\u2013F922","journal-title":"Am J Physiol-Ren Physiol"},{"key":"239_CR76","doi-asserted-by":"publisher","first-page":"107446","DOI":"10.1016\/j.isci.2023.107446","volume":"26","author":"L Tong","year":"2023","unstructured":"Tong L, Rao J, Yang C, Xu J, Lu Y, Zhang Y, Cang X, Xie S, Mao J, Jiang P (2023) Mutational burden of XPNPEP3 leads to defects in mitochondrial complex I and cilia in NPHPL1. iScience 26:107446","journal-title":"iScience"},{"key":"239_CR77","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1016\/j.cmet.2019.09.012","volume":"30","author":"JA Torres","year":"2019","unstructured":"Torres JA, Kruger SL, Broderick C, Amarlkhagva T, Agrawal S, Dodam JR, Mrug M, Lyons LA, Weimbs T (2019) Ketosis ameliorates renal cyst growth in polycystic kidney disease. Cell Metab 30:1007\u20131023.e5","journal-title":"Cell Metab"},{"key":"239_CR78","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1016\/j.kint.2024.07.010","volume":"107","author":"VE Torres","year":"2025","unstructured":"Torres VE, Ahn C, Barten TRM, Brosnahan G, Cadnapaphornchai MA, Chapman AB, Gall EC-L, Drenth JPH, Gansevoort RT, Harris PC et al (2025) KDIGO 2025 clinical practice guideline for the evaluation, management, and treatment of autosomal dominant polycystic kidney disease (ADPKD): executive summary. Kidney Int 107:234\u2013254","journal-title":"Kidney Int"},{"key":"239_CR79","doi-asserted-by":"publisher","first-page":"F1855","DOI":"10.1152\/ajprenal.00025.2018","volume":"315","author":"JF Trott","year":"2018","unstructured":"Trott JF, Hwang VJ, Ishimaru T, Chmiel KJ, Zhou JX, Shim K, Stewart BJ, Mahjoub MR, Jen K-Y, Barupal DK et al (2018) Arginine reprogramming in ADPKD results in arginine-dependent cystogenesis. Am J Physiol-Ren Physiol 315:F1855\u2013F1868","journal-title":"Am J Physiol-Ren Physiol"},{"key":"239_CR80","doi-asserted-by":"publisher","first-page":"2911","DOI":"10.1016\/j.cell.2021.04.002","volume":"184","author":"ME Truong","year":"2021","unstructured":"Truong ME, Bilekova S, Choksi SP, Li W, Bugaj LJ, Xu K, Reiter JF (2021) Vertebrate cells differentially interpret ciliary and extraciliary cAMP. Cell 184:2911\u20132926.e18","journal-title":"Cell"},{"key":"239_CR81","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-12953-5","volume":"10","author":"F Volta","year":"2019","unstructured":"Volta F, Scerbo MJ, Seelig A, Wagner R, O\u2019Brien N, Gerst F, Fritsche A, H\u00e4ring H-U, Zeigerer A, Ullrich S et al (2019) Glucose homeostasis is regulated by pancreatic \u03b2-cell cilia via endosomal EphA-processing. Nat Commun 10:5686","journal-title":"Nat Commun"},{"key":"239_CR82","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-42196-4","volume":"14","author":"RV Walker","year":"2023","unstructured":"Walker RV, Yao Q, Xu H, Maranto A, Swaney KF, Ramachandran S, Li R, Cassina L, Polster BM, Outeda P et al (2023) Fibrocystin\/Polyductin releases a C-terminal fragment that translocates into mitochondria and suppresses cystogenesis. Nat Commun 14:6513","journal-title":"Nat Commun"},{"key":"239_CR83","doi-asserted-by":"publisher","first-page":"1437","DOI":"10.1681\/ASN.2015020132","volume":"27","author":"G Warner","year":"2016","unstructured":"Warner G, Hein KZ, Nin V, Edwards M, Chini CCS, Hopp K, Harris PC, Torres VE, Chini EN (2016) Food restriction ameliorates the development of polycystic kidney disease. J Am Soc Nephrol 27:1437\u20131447","journal-title":"J Am Soc Nephrol"},{"key":"239_CR84","doi-asserted-by":"publisher","first-page":"e12719","DOI":"10.1371\/journal.pone.0012719","volume":"5","author":"C Wodarczyk","year":"2010","unstructured":"Wodarczyk C, Distefano G, Rowe I, Gaetani M, Bricoli B, Muorah M, Spitaleri A, Mannella V, Ricchiuto P, Pema M et al (2010) Nephrocystin-1 forms a complex with polycystin-1 via a polyproline motif\/SH3 domain interaction and regulates the apoptotic response in mammals. PLoS ONE 5:e12719","journal-title":"PLoS ONE"},{"key":"239_CR85","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-38566-y","volume":"9","author":"M Yheskel","year":"2019","unstructured":"Yheskel M, Lakhia R, Cobo-Stark P, Flaten A, Patel V (2019) Anti-microRNA screen uncovers miR-17 family within miR-17~92 cluster as the primary driver of kidney cyst growth. Sci Rep. 9:1920","journal-title":"Sci Rep."},{"key":"239_CR86","doi-asserted-by":"publisher","first-page":"1381","DOI":"10.1681\/ASN.2006111215","volume":"18","author":"BK Yoder","year":"2007","unstructured":"Yoder BK (2007) Role of primary cilia in the pathogenesis of polycystic kidney disease. J Am Soc Nephrol 18:1381\u20131388","journal-title":"J Am Soc Nephrol"},{"key":"239_CR87","doi-asserted-by":"publisher","first-page":"F465","DOI":"10.1152\/ajprenal.00460.2010","volume":"300","author":"D Yoshihara","year":"2011","unstructured":"Yoshihara D, Kurahashi H, Morita M, Kugita M, Hiki Y, Aukema HM, Yamaguchi T, Calvet JP, Wallace DP, Nagao S (2011) PPAR-\u03b3 agonist ameliorates kidney and liver disease in an orthologous rat model of human autosomal recessive polycystic kidney disease. Am J Physiol-Ren Physiol 300:F465\u2013F474","journal-title":"Am J Physiol-Ren Physiol"},{"key":"239_CR88","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-48025-6","volume":"15","author":"C Zhang","year":"2024","unstructured":"Zhang C, Rehman M, Tian X, Pei SLC, Gu J, Bell TA, Dong K, Tham MS, Cai Y, Wei Z et al (2024) Glis2 is an early effector of polycystin signaling and a target for therapy in polycystic kidney disease. Nat Commun 15:3698","journal-title":"Nat Commun"}],"container-title":["EMBO Molecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1038\/s44321-025-00239-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1038\/s44321-025-00239-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1038\/s44321-025-00239-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T00:43:47Z","timestamp":1779065027000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1038\/s44321-025-00239-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,22]]},"references-count":89,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2025,6,12]]}},"alternative-id":["239"],"URL":"https:\/\/doi.org\/10.1038\/s44321-025-00239-x","relation":{},"ISSN":["1757-4684"],"issn-type":[{"value":"1757-4684","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,22]]},"assertion":[{"value":"12 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 April 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 April 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 April 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"AB is an inventor of patents related to metabolic interventions in PKD.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosure and competing interests statement"}}]}}